11 studies found for:    Open Studies | "Coxsackievirus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Coxsackievirus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Ipilimumab
2 Recruiting Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam
Condition: Hand Foot and Mouth Disease
Intervention:
3 Recruiting Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Magnesium Sulphate;   Drug: Sterile water
4 Unknown  A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Drug: Xiyanping Injection;   Drug: Xiyanping Injection with western medicine
5 Unknown  A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Other: Reduning Injection;   Other: Reduning Injection plus western therapy
6 Recruiting Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth Disease
Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid;   Drug: Ribavirin
7 Unknown  A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Herbal concentrate-granules plus western therapy;   Drug: Reduning Injection plus western therapy;   Drug: Western therapy
8 Recruiting A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: CAVATAK (Coxsackievirus A21, CVA21)
9 Recruiting Efficacy and Safety of Intratumoral CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks
Condition: Melanoma
Intervention: Biological: Coxsackievirus A21
10 Recruiting Safety and Clinical Activity of CAVATAK™ Alone or With Low Dose Mitomycin C in Non-muscle Invasive Bladder Cancer
Condition: Non-muscle Invasive Bladder Cancer
Interventions: Biological: CAVATAK;   Drug: Mitomycin C
11 Recruiting Systemic Treatment of Resistant Metastatic Disease
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21

Indicates status has not been verified in more than two years